Back
Green Plains Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
12
GPRE
Green Plains
Last Price:
$5.87
Seasonality Move:
7.91%
Sell
37
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
12
Green Plains (GPRE)
is a Sell
Is Green Plains a Buy, Sell or Hold?
-
The current Green Plains [GPRE] share price is $5.87. The Score for GPRE is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
-
GPRE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
37
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPRE Stock Price Chart
What is Green Plains's stock price today?
-
The Green Plains share price today is $5.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.39The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 28.48 | Sell |
Chaikin Money Flow: | 941465 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.08 - 8.8) | Sell |
Bollinger Bands (100): | (8.12 - 12.06) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | 27952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.12 - 42.26) | Buy |
Bollinger Bands (100): | (24.86 - 48.56) | Buy |
GPRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.13 | Sell |
20-day SMA: | 6.98 | Sell |
50-day SMA: | 8.57 | Sell |
200-day SMA: | 12.83 | Sell |
8-day EMA: | 6.13 | Sell |
20-day EMA: | 6.91 | Sell |
50-day EMA: | 8.3 | Sell |
200-day EMA: | 12.91 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.75 | Buy |
20-day SMA: | 38.76 | Sell |
50-day SMA: | 37.71 | Sell |
200-day SMA: | 18.92 | Buy |
8-day EMA: | 36.45 | Buy |
20-day EMA: | 37.51 | Sell |
50-day EMA: | 37.11 | Buy |
200-day EMA: | 24.13 | Buy |
Green Plains Earnings Growth & GPRE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $1.43 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Green Plains Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |